We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vor Biopharma Inc | NASDAQ:VOR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0153 | 2.34% | 0.67 | 0.6651 | 0.67 | 0.6857 | 0.6633 | 0.6678 | 148,551 | 17:51:54 |
About Vor Biopharma
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.
Contacts:
Investor: Constantine Davides, CFAWestwicke +1 339-970-2846 constantine.davides@westwicke.com
Media: Mary Carmichael Ten Bridge Communications +1 617-413-3543 mary@tenbridgecommunications.com
1 Year Vor Biopharma Chart |
1 Month Vor Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions